BC Week In Review | Feb 7, 2011
Clinical News

BAK-free DuoTrav travoprost/timolol regulatory update

Alcon disclosed in its 4Q10 earnings that it submitted an MAA to the European Medicines Agency (EMA) for a benzalkonium chloride (BAK)-free formulation of DuoTrav travoprost/timolol ophthalmic solution to reduce elevated intraocular pressure (IOP) in...
BC Week In Review | May 3, 2010
Clinical News

DuoTrav travoprost/timolol maleate ophthalmic solution regulatory update

Japan's Ministry of Health, Labor and Welfare approved Alcon's DuoTrav travoprost/timolol ophthalmic solution to treat glaucoma and ocular hypertension. DuoTrav is an isotonic aqueous solution of travoprost, a prostaglandin analog, and timolol, a beta blocker....
Items per page:
1 - 2 of 2